Angiotensin 1-9 vs Catestatin — mechanism, half-life, dosing, and research status compared. Which is right for your protocol?
Angiotensin 1-9 (Ang 1-9) is a 9-amino acid peptide formed when ACE2 cleaves the C-terminal leucine from angiotensin I (Ang I, 10 AA). Discovered as part of the counter-regulatory renin-angiotensin system (RAS), Ang 1-9 opposes the hypertensive and tissue-damaging actions of angi...
Calculate Angiotensin 1-9 dose →Catestatin is a 21-amino acid peptide derived from the chromogranin A (CgA) protein, specifically cleaved from the region spanning residues 352-372. It was identified as an endogenous inhibitor of catecholamine secretion, acting as a non-competitive antagonist at nicotinic acetyl...
Calculate Catestatin dose →| Parameter | Angiotensin 1-9 | Catestatin |
|---|---|---|
| Category | Cardiovascular Peptide | Cardiovascular Peptide |
| Research | Preclinical Research | Preclinical / Early Human |
| Half-Life | ~20-30 minutes | ~15-30 minutes (IV) |
| Typical Dose | 40-400 ng/kg/min IV infusion (animal) | 0.3-3 nmol/kg (animal studies) |
| Frequency | Acute infusion protocols | Acute dosing in research |
| Route | IV/SC (research) | IV (research); intranasal under study |
| FDA Status | Research compound | Research compound |
Use ASCEND's free reconstitution calculator to get exact syringe draw amounts for your vial.
For research use only. Not medical advice. ASCEND does not conduct or endorse any specific research protocol. Always consult relevant scientific literature and regulatory guidelines.